PYXS
Pyxis Oncology, Inc.NASDAQHealthcare$1.48+0.68%ClosedMarket Cap: $93.0M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
10
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed Mar 25 | Wadhane Jitendra | officer: Prin Fin & Acct Officer | Sell | 262,635 | $1.36 | 262,635 |
| Wed Mar 25 | Wadhane Jitendra | officer: Prin Fin & Acct Officer | Sell | 109,461 | $0.00 | 512,882 |
| Wed Mar 25 | Palani Santhosh | director | Sell | 45,867 | $1.36 | 45,867 |
| Wed Mar 25 | Metzger Michael A | director | Sell | 45,867 | $1.36 | 45,867 |
| Wed Mar 25 | Lewis-Hall Freda C | director | Sell | 45,867 | $1.36 | 45,867 |
| Wed Mar 25 | HUMPHREY RACHEL | director | Sell | 1,400 | $0.97 | 95,405 |
| Wed Mar 25 | HUMPHREY RACHEL | director | Sell | 45,867 | $1.36 | 45,867 |
| Wed Mar 25 | FLAVIN JOHN L | director | Sell | 45,867 | $1.36 | 45,867 |
| Wed Mar 25 | Dupont Jakob | director | Sell | 45,867 | $1.36 | 45,867 |
| Wed Mar 25 | Cline Darren S | director | Sell | 45,867 | $1.36 | 45,867 |
| Thu Feb 05 | Civik Thomas | director, officer: Interim CEO | Sell | 690,131 | $1.49 | 690,131 |
| Wed Apr 02 | Wadhane Jitendra | officer: SVP, Chief Accounting Officer | Sell | 263,782 | $0.98 | 263,782 |
| Wed Apr 02 | Sullivan Lara | director, officer: President ,CEO & CMO | Sell | 918,308 | $0.98 | 918,308 |
| Wed Apr 02 | Palani Santhosh | director | Sell | 36,979 | $0.98 | 36,979 |
| Wed Apr 02 | Metzger Michael A | director | Sell | 36,979 | $0.98 | 36,979 |